FDMT NASDAQ
4D Molecular Therapeutics, Inc.
1W: -5.5%
1M: -8.5%
3M: +7.5%
YTD: +86.8%
1Y: +56.6%
3Y: +5.0%
5Y: -61.1%
$13.67
-0.17 (-1.23%)
Weekly Expected Move ±7.2%
$12
$13
$14
$15
$16
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$92M
Revenue
+278712.1% YoY
$-179M
Net Income
+8.7% YoY
$-157M
Free Cash Flow
+7.7% YoY
44.8%
Gross Margin
-2037.2%
Op. Margin
-1929.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-43.3%
ROA-37.1%
ROIC-182.0%
Valuation
P/E-5.0
P/B2.4
EV/EBITDA-3.3
Leverage
Debt/Equity0.10
Current Ratio8.03
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z3.88
Beneish M-3549.86